Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MET amplification + MET overexpression
i
Other names:
DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4233
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MET amplification (66)
MET exon 14 deletion (3)
HER-2 amplification + MET amplification (1)
MET amplification + AXL amplification (1)
MET amplification (66)
MET exon 14 deletion (3)
HER-2 amplification + MET amplification (1)
MET amplification + AXL amplification (1)
›
Associations
(2)
News
Trials
Search handles
@StephenVLiu
Search handles
@StephenVLiu
Filter by
Latest
1year
Dr. Paul Paik explains how to navigate #MET in managing NSCLC. We have capmatinib and tepotinib approved for METex14 mutations - effective (but watch for toxicity). In the future - MET amplification and MET overexpression (IHC) likely to be relevant! #TexasLung23 (@StephenVLiu)
1 year ago
MET (MET proto-oncogene, receptor tyrosine kinase)
|
MET amplification • MET overexpression • MET amplification + MET overexpression
|
Tepmetko (tepotinib) • Tabrecta (capmatinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login